Loading
Envista Holdings Corp Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Keel Paul A, was filed 14 Aug 2024.
Insider Decl.
387
Thresholds
n/a
Buy Volume
€2M
17 ops. · all time
Sell Volume
€37M
84 ops. · all time
Who traded when
BuySaleReis Mischa3 sales
Since the insiders bought
- +14.5%Entry US$18.03 · Close at T+365 US$20.64
- +20.3%Entry US$17.31 · Close at T+365 US$20.82
- -14.9%Entry US$23.95 · Close at T+365 US$20.37
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Envista Holdings Corp Buy (bullish), based on 13 analysts. Average price target: US$28.69.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 15,818 of 26,284 companies
45.2
score / 100
Value48
Quality43
FCF yld6.1%
Earn yld1.2%
EV/EBITDA14.8x
ROE3.1%
Gross mgn55%
Net mgn1.7%
Debt/EBITDA4.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$22.97
Analyst consensus
13 analystsBuy
US$23.00Target US$28.69(+25%)US$34.00
Income statement
RevenueUS$2.7B
Gross profitUS$1.5B55% margin
EBITDAUS$364.5M13% margin
Net incomeUS$47M3.3% margin
Valuation
PER (trailing)39.6x
PER (forward)13.8x
P/Book1.2x
Beta0.89
Balance sheet & cash
Market capUS$3.7B
Total debtUS$1.6B
Free Cash FlowUS$230.4M
Debt / Equity52%
Profitability & ownership
ROE3.1%
ROA3.2%
% insiders0.6%
% institutions120.1%
Last declaration on 27 August 2026
Declarations387 total
7,710 shares@ US$27.470.0054% mcap57.5% of flowCommon StockSEC:0002045846-26-000007:0
5,147 shares@ US$27.470.0036% mcap38.0% of flowCommon StockSEC:0002012361-26-000007:0
10,885 shares@ US$27.470.0076% mcap31.5% of flowCommon StockSEC:0001610493-26-000009:0
804 shares@ US$27.470.0006% mcap49.7% of flowCommon StockSEC:0002045818-26-000005:0
8,000 shares@ US$27.500.0056% mcap10.3% of flowCommonSEC144:0001959173-26-006259
179,730 shares0Common StockSEC:0001626337-26-000010:0
12,811 shares@ US$23.430.0068% mcap8.1% of flowCommon StockSEC:0001626337-26-000005:0
9,330 shares0Common StockSEC:0001563565-26-000003:0
9,330 shares0Common StockSEC:0001278861-26-000008:0
9,330 shares0Common StockSEC:0001306860-26-000003:0
9,330 shares0Common StockSEC:0001308428-26-000003:0
12,585 shares0Common StockSEC:0001365493-26-000003:0
9,330 shares0Common StockSEC:0001410442-26-000005:0
9,330 shares0Common StockSEC:0001886518-26-000007:0
48,670 shares0Common StockSEC:0001626337-26-000004:1
7,605 shares0Common StockSEC:0002045818-26-000002:1
5,915 shares0Common StockSEC:0001788632-26-000006:1
7,605 shares0Common StockSEC:0002012361-26-000004:1
12,675 shares0Common StockSEC:0001755882-26-000004:1
7,605 shares0Common StockSEC:0002045846-26-000004:1
16,055 shares0Common StockSEC:0001610493-26-000004:1
13,520 shares0Common StockSEC:0001993528-26-000003:1
4,964 shares@ US$29.5951.6% of flowCommon StockSEC:0001993528-26-000003:0
11,840 shares@ US$29.599.3% of flowCommon StockSEC:0001626337-26-000004:0
1,412 shares@ US$29.5911.2% of flowCommon StockSEC:0002045846-26-000004:0
25 of 387 declarations
About Envista Holdings Corp
On September 20, 2019, 6 Envista Holdings Corp insiders bought on the same day for EUR 557,542, including Amir Aghdaei (PRESIDENT AND CEO) for EUR 199,122. The largest purchases in the record came later: Paul A. Keel (Chief Executive Officer), EUR 460,217 on August 13, 2024, and Eric D. Hammes (Chief Financial Officer), EUR 366,312 on August 12, 2024. The 17 purchases total EUR 1,772,511 (median EUR 46,014), against 84 sales worth EUR 37,054,733 (median EUR 173,000), or 17% purchases among open-market trades.
The three largest sales are all Amir Aghdaei's (Chief Executive Officer): EUR 5,100,316 on March 17, 2022, EUR 4,006,064 on March 21, 2022 and EUR 3,911,380 on March 22, 2021.
Read moreShow less
The 387 filings from 30 insiders cover trades from September 20, 2019 to August 25, 2026, with 226 grants and 57 option exercises. 2021 is the busiest year, with 141 filings, against 65 in 2022 and 18 in 2019. Over the last twelve months: 35 filings, no purchase, 2 sales. The median delay is 2 days.
For 17 purchases with a stored 90-day result, the median is 8.4% and 82% are positive: stored past results, not a forecast. This US healthcare and pharma company is worth USD 3.7 billion; insiders hold 0.6% of the capital.
